திருப்பம் உயிர் அறிவியல் நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Welcome to Twist Bioscience Fiscal 2021 Second Quarter Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference call over to Jim Thorburn, Chief Financial Officer.
Jim Thorburn
Chief Financial Officer
Thank you, operator. Good afternoon, everyone. I d like to thank all of you for joining us today for Twist Bioscience conference call to review our fiscal 2021 second quarter financial results and business progress. We did issue our financial results earlier this afternoon, which is available at our website at www.twistbioscience.com. With me on today s call is Dr. Emily Leproust, CEO and Co-Founder of Twist. Emily will begin with a review of our recent progress in Twist businesses. I will report on our financial and operational performance. And Emily will discuss our upcoming milestones and direction. We will then open the call for questions. As a reminder, this call is being recorded. The audio portion will be archived in ....

South Africa , Western Cape , Emily Leproust , Jim Thorburn , Exchange Commission , Twist Bioscience Corp , Twist Bioscience Fiscal , Quarter Financial Results Conference , Chief Financial , Twist Bioscience , Chief Executive Officer , Executive Officer , Oligo Pools , Stanford Innovative Medicines Accelerator , Distributed Bio , Twist Biopharma , Data Storage , மேற்கு கேப் , ஜிம் தோர்பர்ன் , பரிமாற்றம் தரகு , திருப்பம் உயிர் அறிவியல் கார்ப் , திருப்பம் உயிர் அறிவியல் நிதி , காலாண்டு நிதி முடிவுகள் மாநாடு , தலைமை நிதி , திருப்பம் உயிர் அறிவியல் , தலைமை நிர்வாகி அதிகாரி ,